Aurora Cannabis Announces Fiscal 2024 Third Quarter Results; Generates Record Adjusted EBITDA of $4.3 Million

Stock Information for Cannabix Technologies Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Cannabix Technologies Inc

Aurora Cannabis Announces Appointment of New Director
Aurora Marks First Shipment of Medical Cannabis to the New Zealand Market
Aurora Improves Offerings in Australia with New Range of Premium Dried Flower Products
Cannabis Market Flourishes Amid Global Legalization, Driving Concerns About Road Safety
Aurora Cannabis Commends Germany's Landmark Legalization Achievement
Aurora Cannabis Achieves Australia's TGA GMP Certification, Setting Global Standard for Quality and Compliance
Aurora Introduces Medical Cannabis Pastilles for Patient Relief in Australia
Aurora Completes Final Repayment of Convertible Senior Notes Representing ~$465 Million in Total Repayments Since 2021; Cannabis Operations Are Now Debt Free[1]

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.